171 related articles for article (PubMed ID: 34638500)
1. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome.
Welter N; Wagner A; Furtwängler R; Melchior P; Kager L; Vokuhl C; Schenk JP; Meier CM; Siemer S; Gessler M; Graf N
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638500
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
[TBL] [Abstract][Full Text] [Related]
3. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.
Ehrlich PF; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Tornwall B; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Dome JS
Cancer; 2020 Aug; 126(15):3516-3525. PubMed ID: 32459384
[TBL] [Abstract][Full Text] [Related]
4. Malformations, genetic abnormalities, and Wilms tumor.
Dumoucel S; Gauthier-Villars M; Stoppa-Lyonnet D; Parisot P; Brisse H; Philippe-Chomette P; Sarnacki S; Boccon-Gibod L; Rossignol S; Baumann C; Aerts I; Bourdeaut F; Doz F; Orbach D; Pacquement H; Michon J; Schleiermacher G
Pediatr Blood Cancer; 2014 Jan; 61(1):140-4. PubMed ID: 23970395
[TBL] [Abstract][Full Text] [Related]
5. [Tumor predisposition syndromes and nephroblastoma : Early diagnosis with imaging].
Welter N; Furtwängler R; Schneider G; Graf N; Schenk JP
Radiologie (Heidelb); 2022 Dec; 62(12):1033-1042. PubMed ID: 36008692
[TBL] [Abstract][Full Text] [Related]
6. Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment.
Liu EK; Suson KD
Transl Androl Urol; 2020 Oct; 9(5):2370-2381. PubMed ID: 33209710
[TBL] [Abstract][Full Text] [Related]
7. Is Nephron Sparing Surgery Justified in Wilms Tumor With Beckwith-Wiedemann Syndrome or Isolated Hemihypertrophy?
Scalabre A; Bergeron C; Brioude F; Dainese L; Cropet C; Coulomb L'hermine A; Pasqualini C; Auber F; Verschuur A; Schleiermacher G; Le Bouc Y; Audry G; Irtan S
Pediatr Blood Cancer; 2016 Sep; 63(9):1571-7. PubMed ID: 27228957
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumor.
MacFarland SP; Duffy KA; Bhatti TR; Bagatell R; Balamuth NJ; Brodeur GM; Ganguly A; Mattei PA; Surrey LF; Balis FM; Kalish JM
Pediatr Blood Cancer; 2018 Oct; 65(10):e27296. PubMed ID: 29932284
[TBL] [Abstract][Full Text] [Related]
9. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
10. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
11. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy.
Choyke PL; Siegel MJ; Craft AW; Green DM; DeBaun MR
Med Pediatr Oncol; 1999 Mar; 32(3):196-200. PubMed ID: 10064187
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group.
Porteus MH; Narkool P; Neuberg D; Guthrie K; Breslow N; Green DM; Diller L
J Clin Oncol; 2000 May; 18(10):2026-31. PubMed ID: 10811666
[TBL] [Abstract][Full Text] [Related]
13. Implications of an Underlying Beckwith-Wiedemann Syndrome for Wilms Tumor Treatment Strategies.
Quarello P; Carli D; Biasoni D; Gerocarni Nappo S; Morosi C; Cotti R; Garelli E; Zucchetti G; Spadea M; Tirtei E; Spreafico F; Fagioli F
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831633
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
[TBL] [Abstract][Full Text] [Related]
15. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.
Furtwängler R; Schmolze M; Gräber S; Leuschner I; Amann G; Schenk JP; Niggli F; Kager L; von Schweinitz D; Graf N
Klin Padiatr; 2014 May; 226(3):175-81. PubMed ID: 24819388
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.
Mussa A; Duffy KA; Carli D; Griff JR; Fagiano R; Kupa J; Brodeur GM; Ferrero GB; Kalish JM
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3115-3123. PubMed ID: 31583434
[TBL] [Abstract][Full Text] [Related]
18. Wilms tumor: an update.
Al-Hussain T; Ali A; Akhtar M
Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
Weirich A; Leuschner I; Harms D; Vujanic GM; Tröger J; Abel U; Graf N; Schmidt D; Ludwig R; Voûte PA
Ann Oncol; 2001 Mar; 12(3):311-9. PubMed ID: 11332141
[TBL] [Abstract][Full Text] [Related]
20. Many faces of Wilms Tumor: Recent advances and future directions.
Bhutani N; Kajal P; Sharma U
Ann Med Surg (Lond); 2021 Apr; 64():102202. PubMed ID: 33747498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
